Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- ABOUT DATAMONITOR HEALTHCARE - page 2
- About the Cardiovascular pharmaceutical analysis team - page 2
- EXECUTIVE SUMMARY - page 4
- Introduction - page 4
- Scope and coverage of the Brief - page 4
- Key findings - page 4
- ATHEROSCLEROSIS OVERVIEW - page 6
- Disease definition - page 6
- Epidemiology - page 7
- Burden of atherosclerosis and coronary heart disease - page 8
- Mortality - page 8
- Cost - page 9
- PREVENTION OF ATHEROSCLEROSIS - page 11
- Atherosclerotic risk factors - page 11
- Hypertension - page 11
- Hypercholesterolemia - page 13
- Overweight and obesity - page 14
- Diabetes - page 14
- Smoking - page 16
- AHA recommendations for the prevention of coronary heart disease - page 17
- Risk factor screening - page 17
- Global risk estimation - page 18
- Risk intervention - page 18
- Blood pressure control - page 18
- Blood lipid management - page 19
- Weight management - page 21
- Dietary intake - page 21
- Physical activity - page 22
- Smoking - page 22
- Aspirin - page 22
- Diabetes mellitus - page 23
- Therapeutic lifestyle changes - page 24
- Drug therapy - page 24
- Antihypertensives - page 24
- Statins - page 25
- Obesity drugs - page 26
- Antidiabetics - page 27
- Metabolic syndrome - page 28
- Metabolic syndrome definition - page 28
- Clinical criteria for diagnosis - page 29
- Metabolic syndrome and coronary heart disease - page 33
- Atherosclerotic risk factors - page 11
- APPENDIX - page 36
- Bibliography - page 36
- Research methodology - page 38
- Disclaimer - page 39
- Bibliography - page 36
- List of Tables
- Table 1: Epidemiology of cardiovascular disease, coronary heart disease and stroke in the US in 2002 - page 7
- Table 2: Disability and mortality burdens of heart disease and stroke in the seven major markets in 2002 - page 9
- Table 3: ATP III diagnostic criteria for metabolic syndrome - page 30
- Table 4: WHO working criteria for metabolic syndrome - page 31
- Table 5: IDF diagnostic criteria for metabolic syndrome - page 32
Other users found this report page using the following search terms: coronary heart disease chd cardiac myocardial heart disease heart lifestyle coronary healthy prevention promoting lifestyles uk changes
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.